Replication of herpes simplex virus in WI-38 cells was inhibited by phosphonoacetic acid, as measured by decreased virus cytopathogenic effect and incorporation of radiolabeled thymidine in virus-infected cells. The drug appeared to have no effect on adsorption, penetration, or release of the virus nor on the synthesis of ribonucleic acid or protein. It appeared to inhibit virus deoxyribonucleic acid synthesis.Herpes simplex virus (HSV) is a frequent infection in man with degrees of severity from mild to severe discomfort (cutaneous lesions) to severe infection damaging the eye sight (herpes keratitis) to severe and life-threatening diseases (herpes encephalitis). It has been suggested recently that herpes-viruses may be directly or indirectly associated with cancer in several animals: frog renal adenocarcinoma (4), malignant lymphomas in chickens (Marek's disease) (11), rabbits (6), and monkeys (8). Herpes-type viruses have been indirectly associated with Burkitt's lymphoma, nasopharyngeal carcinoma (5), and cervical carcinoma (1) in humans. 5-Iodo-2-deoxyuridine and cytosine arabinoside are two well-known nucleoside analogs and are inhibitors of herpervirus replication. Both compounds are quite toxic (2, 12), and 5-iodo-2-deoxyuridine has been shown to be carcinogenic and teratogenic (10).In earlier studies by Shipkowitz et al. (13), phosphonoacetic acid (PAA) was shown to be active against herpes dermatitis in mice and herpes keratitis in rabbits. We report here the efficacy of PAA against HSV in tissue culture, its effect on WI-38 cells, and studies related to the mechanism of action. Infected cells. Virus stock solutions were diluted in MM and were added to confluent WI-38 cells. The virus was allowed to adsorb for 1 h at 37 C. The medium and unadsorbed virus were removed by decanting and the cells were washed twice with MM. Cell cultures were then incubated at 37 C in MM.Drug tests. PAA was prepared from sodium phosphite and sodium chloroacetic acid as described by Nylen (9). Stock solutions were prepared in MM at a concentration of 10 mg/ml. Portions were then added aseptically to cell cultures to give the desired final concentrations of PAA.Ribonucleic acid (RNA), deoxyribonucleic acid (DNA), and protein synthesis. Cultures (1 ml) of WI-38 cells were grown and infected in tubes. At various intervals during the incubation, the cultures were pulse-labeled for 30 min with [14CIthymidine (0.5 MCi), [3Hjuridine (2.5 1Ci), or "4C-labeled amino acid mixtures (0.2 1Ci). PAA was added at the time of HSV adsorption and was continued in the culture medium thereafter. After each 30-min labeling with radioactive materials, triplicate tubes were removed, and then the medium was decanted. The cell layers were washed twice with cold MM. Then, 4 ml of phosphate-buffered saline were added to each tube, and the cells were scraped from the tube wall. Trichloroacetic acid was added to a final concentration of 5%. The mixture was frozen, thawed once, and
Phosphonoacetate is a highly specific inhibitor of herpes simplex virus-induced DNA polymerase. Sensitivity of herpesvirus type 1 or type 2 induced DNA polymerase to the drug was similar. However, DNA polymerases from other sources such as the host cells (Wi-38), Micrococcus luteus, and hepatitis B virus were highly resistant. In addition, Escherichia coli RNA polymerase and reverse transcriptase of Rous sarcoma virus were also insensitive to the drug. Enzyme kinetic studies showed that inhibition was noncompetitive with respect to deoxyribonucleotide triphosphates. The Ki value was about 0.45 muM. The apparent Km values for dTTP, dATP, dCTP, and dGTP were 0.71, 0.75, 0.42, and 0.39 muM, respectively. The base composition of template has no profound effect on the extent of inhibition. The drug caused uncompetititve inhibition with respect to template which indicated that phosphonoacetate did not bind directly to template DNA. Results are presented which suggest that phosphonoacetate did not affect the formation of the enzyme-DNA complex but probably inhibited the elongation step of DNA polymerase reaction.
Infection of Wi-38 cells with herpes simplex virus induced an elevated DNA polymerase activity which had many biochemical properties different from normal cell DNA polymerase. Phosphonoacetic acid specifically inhibited the virus-induced DNA polymerase as compared to the normal WI-38 cell DNA polymerase. The compound did not appear to inhibit enzyme activity by interacting with the DNA primer.
adenosine; GMPPCP, 5'-guanylylmethylenediphosphonate; 1 optical density unit is the amount of material which in 1.0 ml would yield a value of 1.0 for the optical density measured at 260 µ in a cuvet with a path length of 1.0cm.
The effect of erythromycin on peptide-bond formation was studied in a modified fragment reaction. Evidence showed that this reaction was a specific assay for peptidyltransferase. The transfer of monoaminoacyl moieties from tRNA to puromycin was consistently stimulated by erythromycin. On the other hand, the transfer of dipeptidyl moieties such as diphenylalanine, A-acetyldiphenylalanine, -prolylglycine, -phenylalanylglycine, and -phenylalanylleucine from tRNA to puromycin was inhibited by the antibiotic. Nevertheless, the transfer of two dipeptidyl moieties, A-acetyldiglycine and -glycylproline was stimulated by the antibiotic. The degree of stimulation or inhibition was different depending upon the substrates, and complete inhibition was not observed. The maximal effect of erythromycin was observed at an erythromycin concentration of less than 10-6 m. Kinetic studies showed that erythromycin altered the rate of peptidebond formation. The dose-response curve of peptidylpuro-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.